Shijiazhuang, China, July 23, 2019. At the beginning of this year, the leaders of the Shijiazhuang Municipal Government, the Wuhan Municipal Political Consult, the Municipal Health Commission, and the leaders of the East Lake Development Zone jointly decided to use artificial intelligence cervical cancer screening technology to provide high-quality and low-cost screening services for women in Shijiazhuang City.
In just a few months, under the combined efforts of the leaders of Shijiazhuang Maternal and Child Health Hospital and the diagnostic laboratory of Landing Med, the preparatory work was completed. An artificial intelligence laboratory capable of screening millions of cases officially opened today. Trial operations have begun and the laboratory is expected to play an important role in reducing the incidence and mortality of cervical cancer in women in Shijiazhuang.